DexCom
DXCM
#961
Rank
ยฃ18.26 B
Marketcap
ยฃ46.83
Share price
-0.75%
Change (1 day)
-9.24%
Change (1 year)

Revenue for DexCom (DXCM)

Revenue in 2025 (TTM): ยฃ3.47 Billion

According to DexCom's latest financial reports the company's current revenue (TTM ) is ยฃ3.52 Billion. an increase over the revenue in the year 2024 that were of ยฃ3.21 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for DexCom from 2006 to 2025

Annual revenue

Year Revenue Change
2025 ยฃ3.46 B7.72%
2024 ยฃ3.21 B13.03%
2023 ยฃ2.84 B18.21%
2022 ยฃ2.40 B32.6%
2021 ยฃ1.81 B28.33%
2020 ยฃ1.41 B25.58%
2019 ยฃ1.12 B38.5%
2018 ยฃ0.81 B52.87%
2017 ยฃ0.53 B14.42%
2016 ยฃ0.46 B71.28%
2015 ยฃ0.27 B62.94%
2014 ยฃ0.16 B71.64%
2013 ยฃ96.99 M56.99%
2012 ยฃ61.78 M25.92%
2011 ยฃ49.06 M55.76%
2010 ยฃ31.5 M71.68%
2009 ยฃ18.34 M173.39%
2008 ยฃ6.71 M188.18%
2007 ยฃ2.32 M110.27%
2006 ยฃ1.1 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
ยฃ71.25 B 1,920.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ33.53 B 850.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
ยฃ26.84 B 661.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Becton Dickinson
BDX
ยฃ16.58 B 370.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Edwards Lifesciences
EW
ยฃ4.59 B 30.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
ยฃ0.76 B-78.40%๐Ÿ‡บ๐Ÿ‡ธ USA
QuidelOrtho
QDEL
ยฃ2.05 B-41.78%๐Ÿ‡บ๐Ÿ‡ธ USA
West Pharmaceutical Services
WST
ยฃ2.32 B-34.06%๐Ÿ‡บ๐Ÿ‡ธ USA